NCT01746836
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,102 public trials
617 recruiting studies
Leukemia, Myeloid trial results
NCT06548230
- Conditions
- Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06456463
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Stanford Health Care Stanford, California, United States
- University of Miami Miami, Florida, United States
- AdventHealth Cancer Institute Orlando, Florida, United States
NCT07147621
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- University Hospital of Angers Angers, Maine et Loire, France
NCT06543381
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Cleveland Clinic Cancer Center Cleveland, Ohio, United States
Recruiting
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
NCT05672147
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT07033598
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute at Emory Atlanta, Georgia, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States
Recruiting
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
NCT06510868
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT03214562
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Myelodysplastic Syndrome, +7 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
NCT06575296
- Conditions
- Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, +19 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States